Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Mark Cuban, Humana CEO announce drug pricing partnership during Forbes panel
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
Neuralink users reveal power to move robotic arms, play video games with their minds
The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.
Community Health Systems sells ambulatory diagnostics segment to Labcorp for $194M
The all-cash deal is expected to be finalized in April 2026. With this divestment of its ambulatory labs, Tennessee-based Community Health Systems said it will be better able to focus on its core patient care business.
Patient communication AI company receives $65M in funding from private equity
Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.
CVS agrees to pay $38M to resolve insulin over-distribution allegations, DOJ says
Authorities allege the pharmacy chain gave patients more insulin than prescribed and then billed Medicare and Medicaid for the full amounts. This allegedly occurred for more than a decade.

Industry Watcher’s Digest

Having released the latest version of Llama in December, Meta is telling the world that open-source AI is the future of AI in healthcare.

Johnson & Johnson buys depression drug and its manufacturer for $15B

The drug Caplyta, owned by Intra-Cellular Therapies, is being used to treat bipolar disorder and schizophrenia. In 2024, it brought in more than $481 million in sales.

Optum UnitedHealthcare UnitedHealth Group HQ

UnitedHealth, Amedisys ask federal judge to dismiss DOJ lawsuit blocking $3.3B merger

The companies argue that the U.S. Department of Justice has failed to adequately demonstrate how, and in which regions of the country, the merger would harm competition. They are asking a federal court to throw out the case.

UnitedHealth shareholders push company to report on impact of claims denials

The motion is being advanced by religious groups and hedge funds alike, with the decision to develop a report set to be voted on at the UnitedHealth Group 2025 annual meeting.

Healthcare private equity reporting act signed into law by Mass. governor

The new law will require private equity firms to make disclosures related to organizational structure and finances if they intend to operate a medical facility or provider organization in the state.

Industry Watcher’s Digest

Is AI adoption a marathon or a sprint?

Healthcare systems set up at the ACC.24 career fair in hopes of filling open positions, including a large and growing number of general cardiologist positions. Photo by Dave Fornell #ACC24 #ACC2024

Healthcare, AI top list of fastest growing jobs

While artificial intelligence engineers and consultants took the top two spots, physical therapists and advanced practice providers also landed among the 25 fastest growing jobs in the U.S.

$49B in medical debt to be erased from credit reports

A new final rule from the Consumer Financial Protection Bureau bans reporting agencies from including medical debts on credit reports or factoring them into credit scores.

Business Intelligence

Mark Cuban, Humana CEO announce drug pricing partnership during Forbes panel

Neuralink users reveal power to move robotic arms, play video games with their minds

Community Health Systems sells ambulatory diagnostics segment to Labcorp for $194M

Patient communication AI company receives $65M in funding from private equity

CVS agrees to pay $38M to resolve insulin over-distribution allegations, DOJ says